• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

6.650 -0.160 (-2.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
November 14, 2024
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2024 ↗
November 13, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 12, 2024
 
Via Benzinga
News headline image
Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings ↗
November 12, 2024
 
Via Benzinga
Topics Stocks
News headline image
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday ↗
November 12, 2024
 
Via Benzinga
News headline image
Preview: Taysha Gene Therapies's Earnings ↗
November 12, 2024
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights ↗
August 12, 2024
 
Via Benzinga
News headline image
Where Taysha Gene Therapies Stands With Analysts ↗
July 23, 2024
 
Via Benzinga
News headline image
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
November 12, 2024
 
Via Benzinga
News headline image
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024 ↗
August 12, 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today? ↗
June 26, 2024
Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
June 26, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! 
Via InvestorPlace
News headline image
The Analyst Landscape: 16 Takes On Taysha Gene Therapies ↗
June 17, 2024
 
Via Benzinga
News headline image
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views ↗
May 28, 2024
 
Via Benzinga
News headline image
11 Analysts Assess Taysha Gene Therapies: What You Need To Know ↗
April 30, 2024
 
Via Benzinga
News headline image
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
June 26, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 19, 2024
 
Via Benzinga
News headline image
S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings ↗
June 18, 2024
 
Via Benzinga
Topics Stocks
News headline image
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
June 18, 2024
 
Via Benzinga
News headline image
Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts ↗
April 09, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
June 18, 2024
 
Via Benzinga
News headline image
Crude Oil Rises 1%; DermTech Shares Plummet ↗
June 18, 2024
 
Via Benzinga
News headline image
What's Going On With Taysha Gene Therapies Stock Tuesday? ↗
June 18, 2024
Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome. 
Via Benzinga
News headline image
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024 ↗
May 14, 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
April 12, 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday ↗
April 10, 2024
U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
April 09, 2024
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free 
Via Benzinga
News headline image
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗
April 09, 2024
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
Via Benzinga
Topics Stocks
News headline image
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease ↗
March 21, 2024
Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neuropathy. The therapy demonstrated safety and efficacy in children with GAN,... 
Via Benzinga
News headline image
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday ↗
March 21, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap